Hepatitis B Infection (Chronic)

Exposure to HBV-contaminated blood or body fluids initiates infection.

Perinatal transmission during childbirth from an infected mother is a primary inciting event.

Sexual contact with an infected partner introduces the virus to mucosal surfaces.

Use of contaminated needles during intravenous drug use or medical procedures triggers infection.

Blood transfusion with unscreened blood products can cause initial HBV exposure.

Chronic infection is established when HBsAg persists beyond 6 months after acute infection.

The incubation period from exposure to acute hepatitis symptoms ranges from 1 to 4 months.

Progression to cirrhosis or hepatocellular carcinoma may take decades after chronic infection onset.

Immune tolerance phase can last for years with minimal symptoms despite high viral replication.

Transition to immune active phase with liver inflammation may occur after a variable latency.

Many patients are asymptomatic during the immune tolerant phase, delaying diagnosis.

Lack of routine HBV screening in at-risk populations leads to missed chronic infections.

Symptoms of chronic hepatitis are often nonspecific and attributed to other causes.

Misinterpretation of isolated anti-HBc antibody results can delay diagnosis.

Limited access to HBV DNA viral load testing in resource-poor settings impedes timely diagnosis.

Fatigue is the most common symptom in chronic hepatitis B infection.

Right upper quadrant discomfort may occur due to liver inflammation.

Jaundice appears during acute exacerbations or advanced liver disease.

Pruritus can result from cholestasis in chronic liver disease.

Symptoms of portal hypertension such as abdominal distension or gastrointestinal bleeding may develop in cirrhosis.

Patients often report a history of fatigue, malaise, and intermittent right upper quadrant discomfort during immune active phases.

Jaundice and dark urine may occur during acute exacerbations but are uncommon in chronic stable disease.

Symptoms of decompensated cirrhosis such as ascites, encephalopathy, or variceal bleeding develop late.

Some patients remain asymptomatic for years despite ongoing liver inflammation.

History may include prior acute hepatitis episodes or known exposure to HBV.

History of acute hepatitis B infection or other viral hepatitis increases suspicion for chronicity.

Previous blood transfusions, intravenous drug use, or high-risk sexual behavior are relevant exposures.

Immunosuppressive conditions or therapies such as HIV infection or chemotherapy affect disease course.

Prior vaccination status for HBV is important to assess susceptibility.

History of liver disease or cirrhosis from other causes may complicate presentation.

Family members with chronic hepatitis B infection increase risk due to shared exposure or vertical transmission.

A family history of hepatocellular carcinoma suggests possible hereditary or environmental risk factors.

No specific genetic syndromes are associated with chronic HBV, but familial clustering is common in endemic areas.

Relatives with liver cirrhosis may indicate advanced disease progression in the family.

Screening of household contacts is recommended due to high transmission risk.

Hepatomegaly with or without tenderness is common in chronic hepatitis B infection.

Jaundice may be present during active liver inflammation or flare.

Spider angiomas and palmar erythema can indicate chronic liver disease progression.

Ascites and peripheral edema suggest advanced liver dysfunction or cirrhosis.

Gynecomastia may be seen in cirrhosis due to altered hormone metabolism.

Regular monitoring of liver function tests and hepatitis B viral load to assess disease progression and treatment response.

Lifestyle modification including abstinence from alcohol to reduce liver injury and progression to cirrhosis.

Screening and vaccination of household contacts to prevent transmission of hepatitis B virus.